The Population Burden of Heart Failure Attributable to Modifiable Risk Factors The ARIC (Atherosclerosis Risk in Communities) Study

被引:85
|
作者
Avery, Christy L. [1 ]
Loehr, Laura R.
Baggett, Christopher [2 ]
Chang, Patricia P. [3 ]
Kucharska-Newton, Anna M.
Matsushita, Kunihiro [4 ]
Rosamond, Wayne D.
Heiss, Gerardo
机构
[1] Univ N Carolina, Bank Amer Ctr, Dept Epidemiol, Chapel Hill, NC 27514 USA
[2] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27514 USA
[3] Univ N Carolina, Dept Med, Chapel Hill, NC 27514 USA
[4] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
关键词
diabetes; epidemiology; heart failure; ADJUSTED LIFE-YEARS; CARDIOVASCULAR-DISEASE; SURVIVAL; HEALTH; PREVALENCE; OBJECTIVES; FRACTIONS; MORTALITY; ENALAPRIL;
D O I
10.1016/j.jacc.2012.07.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The goal of this study was to estimate the population burden of heart failure and the influence of modifiable risk factors. Background Heart failure is a common, costly, and fatal disorder, yet few studies have evaluated the population-level influence of modifiable risk factors. Methods From 14,709 ARIC (Atherosclerosis Risk in Communities) study participants, we estimated incidence rate differences (IRD) for the association between 5 modifiable risk factors (cigarette smoking, diabetes, elevated low-density lipoproteins, hypertension, and obesity) and heart failure. Potential impact fractions were used to measure expected changes in the heart failure incidence assuming achievement of a 5% proportional decrement in the prevalence of each risk factor. Results Over an average of 17.6 years of follow-up, 1 in 3 African American and 1 in 4 Caucasian participants were hospitalized with heart failure, defined as the first hospitalization with International Classification of Diseases, Ninth Revision discharge codes of 428.x. Of the 5 modifiable risk factors, the largest IRD was observed for diabetes, which was associated with 1,058 (95% confidence interval [CI]: 787 to 1,329) and 660 (95% CI: 514 to 805) incident hospitalizations of heart failure/100,000 person-years among African-American and Caucasian participants, respectively. A 5% proportional reduction in the prevalence of diabetes would result in approximately 53 and 33 fewer incident heart failure hospitalizations per 100,000 person-years in African-American and Caucasian ARIC participants, respectively. When applied to U. S. populations, this reduction may prevent approximately 30,000 incident cases of heart failure annually. Conclusions Modest decrements in the prevalence of modifiable heart failure risk factors such as diabetes may substantially decrease the incidence of this major disease. (J Am Coll Cardiol 2012;60:1640-6) (c) 2012 by the American College of Cardiology Foundation
引用
收藏
页码:1640 / 1646
页数:7
相关论文
共 50 条
  • [31] Shortness of Breath, Edema, and Fatigue and the Risk of Hospitalized Heart Failure (HF). The Atherosclerosis Risk in Communities (ARIC) Study
    Kucharska-Newton, Anna
    Selvin, Elizabeth
    Viera, Anthony
    Keyserling, Thomas
    Shah, Amil
    Ballantyne, Christie
    Agarwal, Sunil
    Camplain, Ricky
    McEvoy, John
    Heiss, Gerardo
    CIRCULATION, 2016, 133
  • [32] Anemia, Chronic Kidney Disease, and Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study
    Ishigami, Junichi
    Grams, Morgan E.
    Naik, Rakhi P.
    Caughey, Melissa C.
    Loehr, Laura R.
    Coresh, Josef
    Matsushita, Kunihiro
    CIRCULATION, 2016, 133
  • [33] Mitochondrial DNA Copy Number and Incident Heart Failure The Atherosclerosis Risk in Communities (ARIC) Study
    Hong, Yun Soo
    Longchamps, Ryan J.
    Zhao, Di
    Castellani, Christina A.
    Loehr, Laura R.
    Chang, Patricia P.
    Matsushita, Kunihiro
    Grove, Megan L.
    Boerwinkle, Eric
    Arking, Dan E.
    Guallar, Eliseo
    CIRCULATION, 2020, 141 (22) : 1823 - 1825
  • [34] The Burden of Cardiovascular Disease Attributable to Major Modifiable Risk Factors in Indonesia
    Hussain, Mohammad Akhtar
    Al Mamun, Abdullah
    Peters, Sanne A. E.
    Woodward, Mark
    Huxley, Rachel R.
    JOURNAL OF EPIDEMIOLOGY, 2016, 26 (10) : 515 - 521
  • [35] White Blood Cell Count, C-Reactive Protein, and Incident Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study
    Bekwelem, Wobo
    Lutsey, Pamela L.
    Loehr, Laura R.
    Agarwal, Sunil K.
    Astor, Brad C.
    Guild, Cameron
    Ballantyne, Christie M.
    Folsom, Aaron R.
    ANNALS OF EPIDEMIOLOGY, 2011, 21 (10) : 739 - 748
  • [36] Associations of lower-limb atherosclerosis and arteriosclerosis with cardiovascular risk factors and disease in older adults: The Atherosclerosis Risk in Communities (ARIC) study
    Stone, Keeron
    Fryer, Simon
    Faulkner, James
    Meyer, Michelle L.
    Heffernan, Kevin
    Kucharska-Newton, Anna
    Zieff, Gabriel
    Paterson, Craig
    Matsushita, Kunihiro
    Hughes, Timothy M.
    Tanaka, Hirofumi
    Stoner, Lee
    ATHEROSCLEROSIS, 2022, 340 : 53 - 60
  • [37] Biomarker Enhanced Risk Prediction of Incident Heart Failure in Low-Risk Patients: The Atherosclerosis Risk in Communities (ARIC) Study
    Chunawala, Zainali
    Khan, Sadiya S.
    Qamar, Arman
    Arora, Sameer
    Fudim, Marat
    Vaduganathan, Muthiah
    Mentz, Robert J.
    Bhatt, Deepak
    Grodin, Justin L.
    Pandey, Ambarish
    Caughey, Melissa C.
    CIRCULATION, 2023, 148
  • [38] Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study
    Ballew, Shoshana H.
    Chen, Yan
    Daya, Natalie R.
    Godino, Job G.
    Windham, B. Gwen
    McAdams-DeMarco, Mara
    Coresh, Josef
    Selvin, Elizabeth
    Grams, Morgan E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (02) : 228 - 236
  • [39] Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study
    Lazo, Mariana
    Chen, Yuan
    McEvoy, John W.
    Ndumele, Chiadi
    Konety, Suma
    Ballantyne, Christie M.
    Sharrett, A. Richey
    Selvin, Elizabeth
    CLINICAL CHEMISTRY, 2016, 62 (09) : 1202 - 1210
  • [40] Global Burden of Gallbladder Cancer Attributable to Modifiable Risk Factors
    Piovani, Daniele
    Nikolopoulos, Georgios K.
    Figlioli, Gisella
    Tsantes, Andreas G.
    Bonovas, Stefanos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (05) : 886 - 890